The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase I Trial of the VEGF Inhibitor SU5416, Incorporating Dynamic Contrast MRI Assessment of Vascular Permeability.
 
Tsutomu Hayashi
No Relationships to Disclose
 
Toru Aoyama
No Relationships to Disclose
 
Hiroshi Yamamoto
Employment - Ajinomoto
Stock and Other Ownership Interests - Ajinomoto
Research Funding - Ajinomoto
 
Takanobu Yamada
No Relationships to Disclose
 
Tsutomu Sato
No Relationships to Disclose
 
Yasushi Rino
No Relationships to Disclose
 
Munetaka Masuda
No Relationships to Disclose
 
Haruhiko Cho
No Relationships to Disclose
 
Akira Tsuburaya
No Relationships to Disclose
 
Takashi Ogata
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Ajinomoto; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; Medtronic; Nihonkayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Research Funding - Chugai Pharma; Novartis; Taiho Pharmaceutical; Yakult Pharmaceutical